Jenniffer Collins Acquires 7,000 Shares of Teligent, Inc. (TLGT) Stock

Teligent, Inc. (NASDAQ:TLGT) CFO Jenniffer Collins bought 7,000 shares of Teligent stock in a transaction that occurred on Wednesday, November 8th. The shares were acquired at an average price of $3.04 per share, for a total transaction of $21,280.00. Following the completion of the transaction, the chief financial officer now directly owns 19,206 shares of the company’s stock, valued at approximately $58,386.24. The acquisition was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Shares of Teligent, Inc. (TLGT) traded up $0.62 on Friday, hitting $3.74. The stock had a trading volume of 2,751,000 shares, compared to its average volume of 406,088. The company has a quick ratio of 3.71, a current ratio of 4.37 and a debt-to-equity ratio of 1.99. Teligent, Inc. has a one year low of $2.82 and a one year high of $9.54.

Teligent (NASDAQ:TLGT) last issued its earnings results on Monday, November 6th. The company reported ($0.08) EPS for the quarter, missing the consensus estimate of ($0.01) by ($0.07). The firm had revenue of $13.65 million during the quarter, compared to analyst estimates of $19.12 million. Teligent had a negative return on equity of 6.38% and a negative net margin of 16.95%. Teligent’s revenue was down 15.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.01 EPS. equities analysts expect that Teligent, Inc. will post -0.13 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: “Jenniffer Collins Acquires 7,000 Shares of Teligent, Inc. (TLGT) Stock” was first published by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this piece of content on another domain, it was stolen and republished in violation of U.S. and international copyright and trademark law. The correct version of this piece of content can be viewed at https://stocknewstimes.com/2017/11/11/jenniffer-collins-acquires-7000-shares-of-teligent-inc-tlgt-stock.html.

Institutional investors and hedge funds have recently modified their holdings of the company. Parkwood LLC acquired a new position in Teligent during the 2nd quarter valued at approximately $112,000. UBS Asset Management Americas Inc. acquired a new position in Teligent during the 1st quarter valued at approximately $170,000. Renaissance Technologies LLC acquired a new position in Teligent during the 1st quarter valued at approximately $198,000. American International Group Inc. boosted its position in Teligent by 7.1% during the 1st quarter. American International Group Inc. now owns 25,488 shares of the company’s stock valued at $199,000 after purchasing an additional 1,680 shares during the period. Finally, Voya Investment Management LLC boosted its position in Teligent by 16.1% during the 2nd quarter. Voya Investment Management LLC now owns 23,342 shares of the company’s stock valued at $214,000 after purchasing an additional 3,234 shares during the period. Institutional investors own 66.44% of the company’s stock.

A number of research firms have recently commented on TLGT. Zacks Investment Research downgraded Teligent from a “hold” rating to a “strong sell” rating in a report on Saturday. Canaccord Genuity downgraded Teligent from a “buy” rating to a “hold” rating and dropped their target price for the company from $9.00 to $5.00 in a report on Tuesday. TheStreet downgraded Teligent from a “c-” rating to a “d+” rating in a report on Wednesday, November 1st. Roth Capital set a $9.00 target price on Teligent and gave the company a “buy” rating in a report on Wednesday, August 23rd. Finally, Deutsche Bank AG dropped their target price on Teligent from $9.00 to $8.00 and set a “hold” rating on the stock in a report on Monday, August 14th. Three research analysts have rated the stock with a sell rating, two have issued a hold rating and one has given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $7.33.

About Teligent

Teligent, Inc is a specialty generic pharmaceutical company. Under the Company’s own label, it markets and sells generic injectable pharmaceutical products in the United States and Canada. In the United States it marketed 16 generic topical pharmaceutical products and four branded generic pharmaceutical products, as of December 31, 2016.

Receive News & Ratings for Teligent Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teligent Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply